{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/115898"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/115898","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Investigations into the biosynthesis and mode of action of the antimicrobial peptides epilancin 15x and sublancin","abstract":"Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2024-08-01","abstract_html":"Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2024-08-01","abstract_has_math":false,"creators":["Wu, Chunyu"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["van der Donk, Wilfred A","Nair, Satish K","Tajkhorshid, Emad","Kehl-Fie, Thomas E"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-08","date_published":"2022-08","updated_at":"2026-07-22T22:24:55Z","subjects":["Peptides","RiPPs","mode of action","bacteria","biosynthesis","antibiotics","lanthipeptides","glycocins"],"languages":["en","eng"],"rights":["Copyright 2022 Chunyu Wu"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2142/115898","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["van der Donk, Wilfred A","Nair, Satish K","Tajkhorshid, Emad","Kehl-Fie, Thomas E"]},{"key":"dc:creator","label":"Author","values":["Wu, Chunyu"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-08","2022-07-11"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Peptides","RiPPs","mode of action","bacteria","biosynthesis","antibiotics","lanthipeptides","glycocins"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en","eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2022 Chunyu Wu"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2142/115898"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2024-08-01","The student, Chunyu Wu, accepted the attached license on 2022-07-07 at 15:54.","The student, Chunyu Wu, submitted this Dissertation for approval on 2022-07-07 at 16:01.","This Dissertation was approved for publication on 2022-07-11 at 12:25.","DSpace SAF Submission Ingestion Package generated from Vireo submission #18171 on 2022-11-16 at 10:17:55","Antimicrobial resistance is a present-day global threat. A rising concern for antimicrobial resistance is the limited number of targets in bacteria affected by our current pool of antibiotics. Over two hundred approved antibacterial drugs target a small number of bacterial processes, including DNA replication, RNA synthesis, protein synthesis, folate synthesis, and cell wall biosynthesis. However, an increasing number of bacterial strains have overcome the action of these antibiotics by developing drug-resistant mutations in the original targets or developing alternative resistance mechanisms. To combat this issue, the discovery of new antibacterial agents that function through novel modes of action is important. Ribosomally-synthesized and post-translationally modified peptide (RiPP) natural products are a rapidly expanding class of compounds, many of which have antimicrobial activity. The molecular target of the majority of RiPPs is currently unknown. The studies described herein focus on the mode of action and biosynthesis of two RiPPs, sublancin 168 and epilancin 15X. Sublancin 168 is one of several characterized members of the glycocin family of RiPPs and contains an unusual S-linked glucose moiety. This unusual post-translational modification leads to a unique antibacterial mode of action. In chapter 2, the mode of action of sublancin was investigated, suggesting that the antimicrobial activity of sublancin is dependent on the phosphoenolpyruvate-phosphotransferase system (PTS). Epilancin 15X is a member of the lanthipeptide family of RiPPs and contains an unusual N-terminal lactate group and eight positively charged amino acids. To understand the correlation between its structure and bioactivity, a novel lanthipeptide heterologous expression system was built, and structure-activity relationship (SAR) studies were performed as described in chapter 3. The new system to heterologously produce class I lanthipeptides in Escherichia coli through co-expressing the producer’s glutamyl-tRNA synthetase (GluRS) and glutamyl-tRNAGlu pair in the vector pEVOL yielded fruitful production of lanthipeptides from both Gram-positive and Gram-negative bacteria. Finally, the mode of action of epilancin 15X was studied in chapter 4, which identified its pore-formation ability through interacting with negatively charged lipids on bacterial membranes."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Investigations into the biosynthesis and mode of action of the antimicrobial peptides epilancin 15x and sublancin"]}]}],"canonical_facts":{"dc:contributor":["van der Donk, Wilfred A","Nair, Satish K","Tajkhorshid, Emad","Kehl-Fie, Thomas E"],"dc:creator":["Wu, Chunyu"],"dc:date":["2022-08","2022-07-11"],"dc:description":["Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2024-08-01","The student, Chunyu Wu, accepted the attached license on 2022-07-07 at 15:54.","The student, Chunyu Wu, submitted this Dissertation for approval on 2022-07-07 at 16:01.","This Dissertation was approved for publication on 2022-07-11 at 12:25.","DSpace SAF Submission Ingestion Package generated from Vireo submission #18171 on 2022-11-16 at 10:17:55","Antimicrobial resistance is a present-day global threat. A rising concern for antimicrobial resistance is the limited number of targets in bacteria affected by our current pool of antibiotics. Over two hundred approved antibacterial drugs target a small number of bacterial processes, including DNA replication, RNA synthesis, protein synthesis, folate synthesis, and cell wall biosynthesis. However, an increasing number of bacterial strains have overcome the action of these antibiotics by developing drug-resistant mutations in the original targets or developing alternative resistance mechanisms. To combat this issue, the discovery of new antibacterial agents that function through novel modes of action is important. Ribosomally-synthesized and post-translationally modified peptide (RiPP) natural products are a rapidly expanding class of compounds, many of which have antimicrobial activity. The molecular target of the majority of RiPPs is currently unknown. The studies described herein focus on the mode of action and biosynthesis of two RiPPs, sublancin 168 and epilancin 15X. Sublancin 168 is one of several characterized members of the glycocin family of RiPPs and contains an unusual S-linked glucose moiety. This unusual post-translational modification leads to a unique antibacterial mode of action. In chapter 2, the mode of action of sublancin was investigated, suggesting that the antimicrobial activity of sublancin is dependent on the phosphoenolpyruvate-phosphotransferase system (PTS). Epilancin 15X is a member of the lanthipeptide family of RiPPs and contains an unusual N-terminal lactate group and eight positively charged amino acids. To understand the correlation between its structure and bioactivity, a novel lanthipeptide heterologous expression system was built, and structure-activity relationship (SAR) studies were performed as described in chapter 3. The new system to heterologously produce class I lanthipeptides in Escherichia coli through co-expressing the producer’s glutamyl-tRNA synthetase (GluRS) and glutamyl-tRNAGlu pair in the vector pEVOL yielded fruitful production of lanthipeptides from both Gram-positive and Gram-negative bacteria. Finally, the mode of action of epilancin 15X was studied in chapter 4, which identified its pore-formation ability through interacting with negatively charged lipids on bacterial membranes."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/2142/115898"],"dc:language":["en","eng"],"dc:rights":["Copyright 2022 Chunyu Wu"],"dc:subject":["Peptides","RiPPs","mode of action","bacteria","biosynthesis","antibiotics","lanthipeptides","glycocins"],"dc:title":["Investigations into the biosynthesis and mode of action of the antimicrobial peptides epilancin 15x and sublancin"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:55Z"}